Bisoprolol

CAS No:
66722-44-9 Category:
  • #LGM Pharma is a Bisoprolol CAS# 66722-44-9 API supplier distributor based in the USA. Inquire about DMF, cGMP, price, availability, delivery, purity, and more.
  • #Questions? Call our customer API support number 1-(800)-881-8210.
  • #LGM Pharma offers this active ingredient but not the finished dosage forms.

Product Details:

  • CAS No: 66722-44-9
  • AHFC code: 24:24.0
  • Synonyms: Bisoprolol Fumarate Bisoprolol fumerate Bisoprolol Hemifumarate
  • ATC Code: C07AB07
  • Chemical Formula: C23H27N
  • Molecular Weight: 325.443
  • Assay/Purity: Typically NLT 98%
  • DrugBank: DB00612 (APRD00257)
  • SMILES: CC(C)NCC(O)COC1=CC=C(COCCOC(C)C)C=C1
  • InChl: VHYCDWMUTMEGQY-UHFFFAOYSA-N
  • PubChem: 2405
  • IUPAC: [2-hydroxy-3-(4-{[2-(propan-2-yloxy)ethoxy]methyl}phenoxy)propyl](propan-2-yl)amine

Additional Details

Indication:
For management of heart failure, angina pectoris, and mild to moderate hypertension and for secondary prevention of myocardial infarction (MI).
Pharmacodynamics:
Bisoprolol is a competitive, cardioselective _1-adrenergic antagonist. Activation of _1-receptors (located mainly in the heart) by epinephrine increases heart rate and the blood pressure causing the heart to consume more oxygen. _1-adrenergic blocking agents such as bisopolol lower the heart rate and blood pressure and may be used to reduce workload on the heart and hence oxygen demands. They are routinely prescribed in patients with ischemic heart disease. In addition, _1-selective blockers prevent the release of renin, a hormone produced by the kidneys causes constriction of blood vessels. Bisoprolol is lipophilic and exhibits no intrinsic sympathomimetic activity (ISA) or membrane-stabilizing activity.
Mode of Action:
Bisoprolol selectively blocks catecholamine stimulation of _1-adrenergic receptors in the heart and vascular smooth muscle. This results in a reduction of heart rate, cardiac output, systolic and diastolic blood pressure, and possibly reflex orthostatic hypotension. At higher doses (e.g. 20 mg and greater) bisoprolol may competitively block _2-adrenergic receptors in bronchial and vascular smooth muscle causing bronchospasm and vasodilation.
Metabolism:
Approximately 50% of the dose is metabolized primarily metabolized by CYP3A4 to inactive metabolites. In vitro studies have shown that bisoprolol is also metabolized by CYP2D6 though this does not appear to be clinically significant. Approximately half the administered dose is excreted in unchanged in urine.
Toxicity:
Oral, mouse: LD50 = 100 mg/kg; Skin, rabbit: LD50 = 200 mg/kg; Skin, rat: LD50 = 500 mg/kg. Symptoms of overdose include congestive heart failure (marked by sudden weight gain, swelling of the legs, feet, and ankles, fatigue, and shortness of breath), difficult or labored breathing, low blood pressure, low blood sugar, and slow heartbeat.
General Reference:
Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271(e)+A13(1). Any patent infringement and resulting liability is solely at buyer risk.

API’s From Quality Manufacturers:

  • Cost effective materials based on specific requirements
  • Small quantities for initial research and larger development quantities towards product commercialization

 

  • Technical packages, letters of access to filed DMFs
  • Complete assistance in any regulatory filings
  • Top quality GMP certified manufacturers
  • Have necessary regulatory credentials

 

Related YouTube Videos